1. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma 
Nishitha M. Reddy, Olalekan Oluwole, John P. Greer, Brian G. Engelhardt, Madan H. Jagasia, Bipin N. Savani 
Experimental Hematology 
Volume 42, Issue 1, Pages (January 2014)
DOI: /j.exphem
Copyright © 2014 ISEH - Society for Hematology and Stem Cells Terms and Conditions

2. Figure 1 (A) Overall survival. (B) Progression-free survival.
Experimental Hematology  , 39-45DOI: ( /j.exphem )
Copyright © 2014 ISEH - Society for Hematology and Stem Cells Terms and Conditions

3. Figure 2
(A) Histology and survival after SCT. (B) Histology and PFS after SCT.
Experimental Hematology  , 39-45DOI: ( /j.exphem )
Copyright © 2014 ISEH - Society for Hematology and Stem Cells Terms and Conditions

4. Figure 3
(A) Disease status before SCT and survival. (B) Disease status before SCT and PFS.
Experimental Hematology  , 39-45DOI: ( /j.exphem )
Copyright © 2014 ISEH - Society for Hematology and Stem Cells Terms and Conditions

5. Figure 4
(A) Number of regimens for SCT and survival. (B) Number regimens before SCT and PFS.
Experimental Hematology  , 39-45DOI: ( /j.exphem )
Copyright © 2014 ISEH - Society for Hematology and Stem Cells Terms and Conditions